Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme
Nanobodies® (VHH antibodies), are small peptides that represent the antigen binding domain, VHH of unique single domain antibodies (heavy chain only antibodies, HcAb) derived from camelids. Here, we demonstrate production of VHH nanobodies against the SARS-CoV-2 spike proteins in the solanaceous pla...
Main Authors: | Marco Pitino, Laura A. Fleites, Lauren Shrum, Michelle Heck, Robert G. Shatters |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.1045337/full |
Similar Items
-
Generation of high affinity ICAM-1-specific nanobodies and evaluation of their suitability for allergy treatment
by: Ines Zettl, et al.
Published: (2022-11-01) -
Nanobody and Its Therapeutic Applications
by: Maryam Darvish
Published: (2018-04-01) -
Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
by: Mohadeseh Haji Abdolvahab, et al.
Published: (2024-02-01) -
Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer
by: Hamid Bakherad, et al.
Published: (2022-08-01) -
Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer
by: Maryam Hosseindokht, et al.
Published: (2021-10-01)